Gullain Barre Syndrome is an autoimmune disorder where the body's immune system attacks the peripheral nervous system, causing demyelination of nerve fibers and impairing nerve conduction. It is often preceded by a viral or bacterial infection. Clinical manifestations include ascending muscle weakness, loss of reflexes, numbness, and paralysis. Diagnosis involves physical exam findings, elevated cerebrospinal fluid protein, and electrodiagnostic testing. Treatment focuses on immunotherapy to reduce antibodies, respiratory support, and prevention of complications like infections and blood clots.
AUTOIMMUNE DISORDERS OF NERVOUS SYSTEMANILKUMAR BR
Autoimmune disorders of the nervous system can attack the central nervous system (CNS), Autoimmune disorders affecting both the central and peripheral nervous system.) which includes the brain and spinal cord, or the peripheral nervous system, consisting of nerves that connect the CNS with the limbs and organs.
The most common disorders are multiple sclerosis and myasthenia gravis.
Autoimmune nervous system disorders include:
Multiple sclerosis
Myasthenia gravis
Guillain-Barré syndrome. (GB Syndrome)
Acute onset infection
Monophasic immune mediated polyneuropathy
Rapid progressive motor paralysis
Affects people of all ages and is not hereditary
Post infectious disease
It can follow by systemic infections
Auto immune in nature
OTHER TERMS
Acute inflammatory demyelinating poly radiculopathy (AIDP)
Acute idiopathic poly radiculo neuritis
Acute idiopathic neuritis
French polio
Landry Guillain Barre Syndrome
TYPES - Acute inflammatory demyelinating poly radiculo neuropathy (AIDP)
Acute Motor Axonal neuropathy(AMDN)
Acute Motor &Sensory Axonal neuropathy(AMSAN)
Miller Fisher Syndrome(MFS)
Polyneuritis Cranialis
CLINICAL MANIFESTATIONS
Paresthesia is frequent followed by paralysis in the extremities
Hypotonia
Areflexia Autonomic dysfunctions include orthostatic hypotension
Hypertension
Abnormal vagal responses
Bowel and bladder dysfunction
Facial flushing
Diaphoresis
Syndrome of inappropriate anti diuretic hormoneProgression of Guillain barre syndrome
include lower brain stem that involves the
Facial Nerve
Abducens Nerve
Oculo Motor Nerve
Hypoglossal Nerve
Trigeminal Nerve
Vagus Nerve
Pain Is a common symptom and It becomes worse at Night.
TREATMENT
On set to two weeks: Plasma pheresis (40-50 ml/kg four times a week
After two weeks: intravenous administration of high dose immunoglobulin (Sandoglobulin)
Beyond three weeks: plasma exchange and immunoglobulin therapies
Chest Physiotherapy
Artificial ventilation-Maintain Gas Exchange
COMPLICATIONS
Cardiac arrhythmias
Respiratory failures
Dys autonomia
Pneumonia
Adult Respiratory Distress Syndrome
Septicemia
Death
AUTOIMMUNE DISORDERS OF NERVOUS SYSTEMANILKUMAR BR
Autoimmune disorders of the nervous system can attack the central nervous system (CNS), Autoimmune disorders affecting both the central and peripheral nervous system.) which includes the brain and spinal cord, or the peripheral nervous system, consisting of nerves that connect the CNS with the limbs and organs.
The most common disorders are multiple sclerosis and myasthenia gravis.
Autoimmune nervous system disorders include:
Multiple sclerosis
Myasthenia gravis
Guillain-Barré syndrome. (GB Syndrome)
Acute onset infection
Monophasic immune mediated polyneuropathy
Rapid progressive motor paralysis
Affects people of all ages and is not hereditary
Post infectious disease
It can follow by systemic infections
Auto immune in nature
OTHER TERMS
Acute inflammatory demyelinating poly radiculopathy (AIDP)
Acute idiopathic poly radiculo neuritis
Acute idiopathic neuritis
French polio
Landry Guillain Barre Syndrome
TYPES - Acute inflammatory demyelinating poly radiculo neuropathy (AIDP)
Acute Motor Axonal neuropathy(AMDN)
Acute Motor &Sensory Axonal neuropathy(AMSAN)
Miller Fisher Syndrome(MFS)
Polyneuritis Cranialis
CLINICAL MANIFESTATIONS
Paresthesia is frequent followed by paralysis in the extremities
Hypotonia
Areflexia Autonomic dysfunctions include orthostatic hypotension
Hypertension
Abnormal vagal responses
Bowel and bladder dysfunction
Facial flushing
Diaphoresis
Syndrome of inappropriate anti diuretic hormoneProgression of Guillain barre syndrome
include lower brain stem that involves the
Facial Nerve
Abducens Nerve
Oculo Motor Nerve
Hypoglossal Nerve
Trigeminal Nerve
Vagus Nerve
Pain Is a common symptom and It becomes worse at Night.
TREATMENT
On set to two weeks: Plasma pheresis (40-50 ml/kg four times a week
After two weeks: intravenous administration of high dose immunoglobulin (Sandoglobulin)
Beyond three weeks: plasma exchange and immunoglobulin therapies
Chest Physiotherapy
Artificial ventilation-Maintain Gas Exchange
COMPLICATIONS
Cardiac arrhythmias
Respiratory failures
Dys autonomia
Pneumonia
Adult Respiratory Distress Syndrome
Septicemia
Death
Guillain Barre Syndrome is characterized by the emergence of distal, relatively symmetrical paraesthesia. It occurs when the bodys defensive mechanisms mistakenly assault parts of the neurological system. It is classified into subtypes as Acute inflammatory demyelinating polyneuropathy AIDP ,Acute motor axonal neuropathy AMAN ,Acute motor sensory axonal neuropathy AMSAN ,Pharyngeal-cervical brachial variant, and Miller Fisher syndrome.GBS can be caused by a variety of infections such as Campylobacter jejuni infection, cytomegalovirus, Epstein Barr virus, and Human Immunodeficiency virus. It mainly causes the motor, sensory, and autonomic dysfunction. In the diagnosis of GBS, a lumbar puncture is an important diagnostic tool.Anti GD1a is linked to the GBS subtype AMAN. Miller Fisher syndrome is linked to anti GQ1b.Its treatment includes, Plasma exchange, Immunoglobulin, and corticosteroids. As it is incurable, supportive care and respiratory support is recommended. Preethi T | Jayaprakash U | Deborah Rose | K C Arul Prakasam "Guillain Barre Syndrome - A Review" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-6 | Issue-3 , April 2022, URL: https://www.ijtsrd.com/papers/ijtsrd49745.pdf Paper URL: https://www.ijtsrd.com/pharmacy/other/49745/guillain-barre-syndrome--a-review/preethi-t
Pediatrics notes about "Acute flaccid paralysis". These notes were published in 2018.
You can download them from
- Telegram: https://t.me/pediatric_notes_2018
- Mediafire: http://www.mediafire.com/folder/u5u60m184t9z7/Pediatric_Notes_2018
Guillain Barre Syndrome (GBS) is a serious disorder that occurs when the body’s defense (immune) system mistakenly attacks part of the nervous system i.e Autoimmune Disorder.
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
Guillain Barre Syndrome is characterized by the emergence of distal, relatively symmetrical paraesthesia. It occurs when the bodys defensive mechanisms mistakenly assault parts of the neurological system. It is classified into subtypes as Acute inflammatory demyelinating polyneuropathy AIDP ,Acute motor axonal neuropathy AMAN ,Acute motor sensory axonal neuropathy AMSAN ,Pharyngeal-cervical brachial variant, and Miller Fisher syndrome.GBS can be caused by a variety of infections such as Campylobacter jejuni infection, cytomegalovirus, Epstein Barr virus, and Human Immunodeficiency virus. It mainly causes the motor, sensory, and autonomic dysfunction. In the diagnosis of GBS, a lumbar puncture is an important diagnostic tool.Anti GD1a is linked to the GBS subtype AMAN. Miller Fisher syndrome is linked to anti GQ1b.Its treatment includes, Plasma exchange, Immunoglobulin, and corticosteroids. As it is incurable, supportive care and respiratory support is recommended. Preethi T | Jayaprakash U | Deborah Rose | K C Arul Prakasam "Guillain Barre Syndrome - A Review" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-6 | Issue-3 , April 2022, URL: https://www.ijtsrd.com/papers/ijtsrd49745.pdf Paper URL: https://www.ijtsrd.com/pharmacy/other/49745/guillain-barre-syndrome--a-review/preethi-t
Pediatrics notes about "Acute flaccid paralysis". These notes were published in 2018.
You can download them from
- Telegram: https://t.me/pediatric_notes_2018
- Mediafire: http://www.mediafire.com/folder/u5u60m184t9z7/Pediatric_Notes_2018
Guillain Barre Syndrome (GBS) is a serious disorder that occurs when the body’s defense (immune) system mistakenly attacks part of the nervous system i.e Autoimmune Disorder.
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
Defecation
Normal defecation begins with movement in the left colon, moving stool toward the anus. When stool reaches the rectum, the distention causes relaxation of the internal sphincter and an awareness of the need to defecate. At the time of defecation, the external sphincter relaxes, and abdominal muscles contract, increasing intrarectal pressure and forcing the stool out
The Valsalva maneuver exerts pressure to expel faeces through a voluntary contraction of the abdominal muscles while maintaining forced expiration against a closed airway. Patients with cardiovascular disease, glaucoma, increased intracranial pressure, or a new surgical wound are at greater risk for cardiac dysrhythmias and elevated blood pressure with the Valsalva maneuver and need to avoid straining to pass the stool.
Normal defecation is painless, resulting in passage of soft, formed stool
CONSTIPATION
Constipation is a symptom, not a disease. Improper diet, reduced fluid intake, lack of exercise, and certain medications can cause constipation. For example, patients receiving opiates for pain after surgery often require a stool softener or laxative to prevent constipation. The signs of constipation include infrequent bowel movements (less than every 3 days), difficulty passing stools, excessive straining, inability to defecate at will, and hard feaces
IMPACTION
Fecal impaction results from unrelieved constipation. It is a collection of hardened feces wedged in the rectum that a person cannot expel. In cases of severe impaction the mass extends up into the sigmoid colon.
DIARRHEA
Diarrhea is an increase in the number of stools and the passage of liquid, unformed feces. It is associated with disorders affecting digestion, absorption, and secretion in the GI tract. Intestinal contents pass through the small and large intestine too quickly to allow for the usual absorption of fluid and nutrients. Irritation within the colon results in increased mucus secretion. As a result, feces become watery, and the patient is unable to control the urge to defecate. Normally an anal bag is safe and effective in long-term treatment of patients with fecal incontinence at home, in hospice, or in the hospital. Fecal incontinence is expensive and a potentially dangerous condition in terms of contamination and risk of skin ulceration
HEMORRHOIDS
Hemorrhoids are dilated, engorged veins in the lining of the rectum. They are either external or internal.
FLATULENCE
As gas accumulates in the lumen of the intestines, the bowel wall stretches and distends (flatulence). It is a common cause of abdominal fullness, pain, and cramping. Normally intestinal gas escapes through the mouth (belching) or the anus (passing of flatus)
FECAL INCONTINENCE
Fecal incontinence is the inability to control passage of feces and gas from the anus. Incontinence harms a patient’s body image
PREPARATION AND GIVING OF LAXATIVESACCORDING TO POTTER AND PERRY,
An enema is the instillation of a solution into the rectum and sig
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
Telehealth Psychology Building Trust with Clients.pptxThe Harvest Clinic
Telehealth psychology is a digital approach that offers psychological services and mental health care to clients remotely, using technologies like video conferencing, phone calls, text messaging, and mobile apps for communication.
Explore our infographic on 'Essential Metrics for Palliative Care Management' which highlights key performance indicators crucial for enhancing the quality and efficiency of palliative care services.
This visual guide breaks down important metrics across four categories: Patient-Centered Metrics, Care Efficiency Metrics, Quality of Life Metrics, and Staff Metrics. Each section is designed to help healthcare professionals monitor and improve care delivery for patients facing serious illnesses. Understand how to implement these metrics in your palliative care practices for better outcomes and higher satisfaction levels.
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
How many patients does case series should have In comparison to case reports.pdfpubrica101
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
ICH Guidelines for Pharmacovigilance.pdfNEHA GUPTA
The "ICH Guidelines for Pharmacovigilance" PDF provides a comprehensive overview of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines related to pharmacovigilance. These guidelines aim to ensure that drugs are safe and effective for patients by monitoring and assessing adverse effects, ensuring proper reporting systems, and improving risk management practices. The document is essential for professionals in the pharmaceutical industry, regulatory authorities, and healthcare providers, offering detailed procedures and standards for pharmacovigilance activities to enhance drug safety and protect public health.
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
2. GULLAIN BARRE SYNDROME
Definition: -
(Auto immune disorder)
It is an autoimmune attack on the peripheral nerve myelin. The result is acute,
rapid segmental demyelination and inflammation of peripheral nerves and
some cranial nerves causing loss of peripheral neurotransmission.
•GBS is characterized by dyskinesia
•Hyporeflexia and paraesthesia (numbness)
3. Aetiology: -
1. Antecedent event
2. Viral infection.(Campylobacter jejuni, Cytomegalovirus, Epstein - Barr virus
, Mycoplasma pneumonia, Haemophilus influenzae ,HIV.
3. Trauma, Surgery to the brain tissue, Peripheral nerves.
4. Viral immunization produce autoimmune antibodies.
Pathophysiology: -
4. Due to etiological factors
Cell mediated and humoral immune attack
On the peripheral nerve myelin protein inflammatory demyelination.
The immune system is unable to distinguish between the two proteins
Attacks and destroys the exact location is peripheral nerve myelin
Ganglioside GMIB destruction of myelin
The axon unable to support nerve conduction
Bulbar weakness, neuromuscular respiratory - weakness
Respiratory failure Glossopharyngeal & Vagus nerve Dysphasia.
5. Mechanism of inflammation→ molecular mimicry in which the infectious
organism contains an amino acids →that mimics the peripheral nerve myelin
protein. The immune system is unable to distinguish between the two
proteins,and an autoimmune reaction occurs.
Clinical manifestations: -
•Muscle weakness
•Hyperreflexia of lower extremities
•Tetraplegia
•Neuromuscular respiratory failure.
•Paraesthesia of the hands & feet at night
•Pain of the hands & feet at night
•Weakness of legs progressed upward.
6. If cranial nerve demyelination causes: -
1. Optic nerve demyelination causes Blindness, ophthalmoplegia
2.Glossopharyngeal & vagus nerve demyelination inability to swallow / clear
secretions.
3.Vagus nerve demyelination causes autonomic dysfunction leads to instability
of cardiovascular System and causes
•Tachycardia Bradycardia
•Hypertension
7. • Orthostatic hypotension, Heart asystole
• Areflexia
• Ascending weakness. (Variation in presentation occurs)-Sensory, Motor
• Paralysis of the ocular muscles’ ataxia
• SIADH
• Appetite & sleep
Diagnostic evaluation: -
1. Physical examination- the following symptoms will be present:-
a. Symmetric weakness
b. Hypo reflexes
c. upward progression of motor weakness
2. Past positive history of viral illness before a few weeks.
3. Changes in vital capacity and negative Inspiratory force.
8. 4. Serum laboratory Studies - increased protein levels
5. CSF evaluation → Increased protein level without an increase in other
cells(7g/l)
6. Evoked potential Studios - decreased nerve conduction velocity (EMG)
Complications: -
1. Resp. failure
2. UTI
3. Paralytic illness, Muscle atrophy, DVT, Pulmonary embolism skin break
down
4. Orthostatic hypotension
5. Nutritional deficiencies
Medical Management: -
1. Respiratory therapy/ mechanical ventilation.
2. Preventing complications of immobility (Thrombosis & pulmonary emboli)
9. •Thigh-high elastic compression stockings
•Sequential compression boots Continuous
electrocardiographic monitoring
Medical Management of GBS
Sl
no
Drug group Action/
indication
Example Contraindication
1 Plasma IVIG,
Plasma
exchange
Decrease the
circulatory
antibody level
IVIG Patient must be assessed for allergic reactions and
provide adequate hydration before infusion of IVIG
2 Short acting
alpha
adrenergic
blocking agent
Control
hypertension
and tachycardia
Doxazosin Terazosin
Prazosin
Provide adequate bed rest. Monitor vitals, cardiac
parameters closely
3 Corticosteroid Reduce
inflammation
IV
Methylprednisolon e
Combined with Immunotherapy will be effective.
4 IV fluid Prevent
Hypotension
Blood plasma Monitor the symptoms of fluid overload.
10. Nursing Management of Guillain Barre Syndrome
1.Ineffective breathing pattern and impaired gas exchange related to rapidly
progressive weakness.
2.Impaired physical mobility related to paralysis.
3.Imbalanced nutrition less than body requirements related to swallowing
disability.
4.Impaired verbal communication related to cranial nerve dysfunction.
5.Fear and anxiety related to loss of control of muscles.
6.Potential for respiratory failure.
7.Potential for Autonomic dysfunction.